The increasing value of plant-made proteins

Current Opinion in Biotechnology

Volumn 32, Issue , 2015, Pages 163-170

  Sack, Markus ^a   Hofbauer, Anna ^b   Fischer, Rainer ^a,c   Stoger, Eva ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; COST ENGINEERING;

BIOENCAPSULATION; BIOPROCESS OPTIMIZATION; DOWNSTREAM-PROCESSING; INNOVATIVE PRODUCT; MEDIUM OPTIMIZATION; MINIMALLY PROCESSED; MUCOSAL DELIVERY; PRODUCTION SYSTEM;

PROTEINS;

H 5; HEPATITIS A VACCINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INFLUENZA VACCINE; MAPP 66; PRX 102; PRX 12; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT PROTEIN; TALIGLUCERASE ALFA; UNCLASSIFIED DRUG; VEN 100; VEN 120; VEN 130; DRUG; VEGETABLE PROTEIN;

CELL ENGINEERING; COST EFFECTIVENESS ANALYSIS; DOWNSTREAM PROCESSING; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG TARGETING; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; HUMAN; MUCOSAL ADMINISTRATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROCESS OPTIMIZATION; PROTEIN SYNTHESIS; QUALITY CONTROL; REVIEW; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; MUCOSA; PLANT; PROTEIN ENGINEERING;

ANIMALS; HUMANS; MUCOUS MEMBRANE; PHARMACEUTICAL PREPARATIONS; PLANT PROTEINS; PLANTS; PROTEIN ENGINEERING;

EID: 84920996444     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.12.008     Document Type: Review

References (69)

1. Qiu X., Wong G., Audet J., Bello A., Fernando L., Alimonti J.B., Fausther-Bovendo H., Wei H., Aviles J., Hiatt E., et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014, 514:47-53.
2. D'Aoust M.A., Couture M.M., Charland N., Trepanier S., Landry N., Ors F., Vezina L.P. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010, 8:607-619.
3. Vamvaka E., Twyman R.M., Christou P., Capell T. Can plant biotechnology help break the HIV-malaria link?. Biotechnol Adv 2014, 32:575-582.
4. Duvenage L., Hitzeroth I.I., Meyers A.E., Rybicki E.P. Expression in tobacco and purification of beak and feather disease virus capsid protein fused to elastin-like polypeptides. J Virol Methods 2013, 191:55-62.
5. Kolotilin I., Kaldis A., Devriendt B., Joensuu J., Cox E., Menassa R. Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco. PLoS One 2012, 7:e42405.
6. Virdi V., Coddens A., De Buck S., Millet S., Goddeeris B.M., Cox E., De Greve H., Depicker A. Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection. Proc Natl Acad Sci USA 2013, 110:11809-11814.
7. Clarke J.L., Waheed M.T., Lossl A.G., Martinussen I., Daniell H. How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?. Plant Mol Biol 2013, 83:33-40.
8. Kwon K.C., Verma D., Singh N.D., Herzog R., Daniell H. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 2013, 65:782-799.
9. Virdi V., Depicker A. Role of plant expression systems in antibody production for passive immunization. Int J Dev Biol 2013, 57:587-593.
10. Lee G., Na Y.J., Yang B.G., Choi J.P., Seo Y.B., Hong C.P., Yun C.H., Kim D.H., Sohn E.J., Kim J.H., et al. Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection. Plant Biotechnol J 2015, 13:62-72. 10.1111/pbi.12235.
11. Lakshmi P.S., Verma D., Yang X., Lloyd B., Daniell H. Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One 2013, 8:e54708.
12. Shenoy V., Kwon K.C., Rathinasabapathy A., Lin S., Jin G., Song C., Shil P., Nair A., Qi Y., Li Q., et al. Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension 2014, 64:1248-1259.
13. Sherman A., Su J., Lin S., Wang X., Herzog R.W., Daniell H. Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood 2014, 124:1659-1668.
14. Shil P.K., Kwon K.C., Zhu P., Verma A., Daniell H., Li Q. Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. Mol Ther 2014, 22:2069-2082.
15. Iizuka M., Wakasa Y., Tsuboi H., Asashima H., Hirota T., Kondo Y., Matsumoto I., Takaiwa F., Sumida T. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen. Plant Biotechnol J 2014, 12:1143-1152.
16. Kohli N., Westerveld D.R., Ayache A.C., Verma A., Shil P., Prasad T., Zhu P., Chan S.L., Li Q., Daniell H. Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers. Mol Ther 2014, 22:535-546.
17. Saeki M., Nishimura T., Kaminuma O., Mori A., Hiroi T. Oral immunotherapy for allergic diseases using transgenic rice seeds: current state and future prospects. Int Arch Allergy Immunol 2013, 161(Suppl. 2):164-169.
18. Kawakatsu T., Kawahara Y., Itoh T., Takaiwa F. A whole-genome analysis of a transgenic rice seed-based edible vaccine against cedar pollen allergy. DNA Res 2013, 20:623-631.
19. Juarez P., Fernandez-del-Carmen A., Rambla J.L., Presa S., Mico A., Granell A., Orzaez D. Evaluation of unintended effects in the composition of tomatoes expressing a human immunoglobulin A against rotavirus. J Agric Food Chem 2014, 62:8158-8168.
20. Cabanos C., Kato N., Amari Y., Fujiwara K., Ohno T., Shimizu K., Goto T., Shimada M., Kuroda M., Masuda T., et al. Development of a novel transgenic rice with hypocholesterolemic activity via high-level accumulation of the alpha' subunit of soybean beta-conglycinin. Transgenic Res 2014, 23:609-620.
21. Vasilev N., Gromping U., Lipperts A., Raven N., Fischer R., Schillberg S. Optimization of BY-2 cell suspension culture medium for the production of a human antibody using a combination of fractional factorial designs and the response surface method. Plant Biotechnol J 2013, 11:867-874.
22. Engler C., Youles M., Gruetzner R., Ehnert T.M., Werner S., Jones J.D., Patron N.J., Marillonnet S. A golden gate modular cloning toolbox for plants. ACS Synth Biol 2014, 3:839-843.
23. Sarrion-Perdigones A., Palaci J., Granell A., Orzaez D. Design and construction of multigenic constructs for plant biotechnology using the GoldenBraid cloning strategy. Methods Mol Biol 2014, 1116:133-151.
24. Hood E.E., Devaiah S.P., Fake G., Egelkrout E., Teoh K.T., Requesens D.V., Hayden C., Hood K.R., Pappu K.M., Carroll J., et al. Manipulating corn germplasm to increase recombinant protein accumulation. Plant Biotechnol J 2012, 10:20-30.
25. Takaiwa F. Increasing the production yield of recombinant protein in transgenic seeds by expanding the deposition space within the intracellular compartment. Bioengineered 2013, 4:136-139.
26. De Meyer T., Depicker A. Trafficking of endoplasmic reticulum-retained recombinant proteins is unpredictable in Arabidopsis thaliana. Front Plant Sci 2014, 5:473.
27. Kudo K., Ohta M., Yang L., Wakasa Y., Takahashi S., Takaiwa F. ER stress response induced by the production of human IL-7 in rice endosperm cells. Plant Mol Biol 2013, 81:461-475.
28. Feeney M., Frigerio L., Kohalmi S.E., Cui Y., Menassa R. Reprogramming cells to study vacuolar development. Front Plant Sci 2013, 4:493.
29. Arcalis E., Ibl V., Peters J., Melnik S., Stoger E. The dynamic behavior of storage organelles in developing cereal seeds and its impact on the production of recombinant proteins. Front Plant Sci 2014, 5:439.
30. Niemer M., Mehofer U., Torres Acosta J.A., Verdianz M., Henkel T., Loos A., Strasser R., Maresch D., Rademacher T., Steinkellner H., et al. The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms. Biotechnol J 2014, 9:493-500.
31. Mandal M.K., Fischer R., Schillberg S., Schiermeyer A. Inhibition of protease activity by antisense RNA improves recombinant protein production in Nicotiana tabacum cv Bright Yellow 2 (BY-2) suspension cells. Biotechnol J 2014, 9:1065-1073.
32. Robert S., Khalf M., Goulet M.C., D'Aoust M.A., Sainsbury F., Michaud D. Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana. PLoS One 2013, 8:e37020.
33. Goulet C., Khalf M., Sainsbury F., D'Aoust M.A., Michaud D. A protease activity-depleted environment for heterologous proteins migrating towards the leaf cell apoplast. Plant Biotechnol J 2012, 10:83-94.
34. Pillay P., Schluter U., van Wyk S., Kunert K.J., Vorster B.J. Proteolysis of recombinant proteins in bioengineered plant cells. Bioengineered 2014, 5:15-20.
35. Strasser R., Altmann F., Steinkellner H. Controlled glycosylation of plant-produced recombinant proteins. Curr Opin Biotechnol 2014, 30C:95-100.
36. Piron R., De Koker S., De Paepe A., Goossens J., Grooten J., Nauwynck H., Depicker A. Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity. PLoS One 2014, 9:e91386.
37. Phan H.T., Hause B., Hause G., Arcalis E., Stoger E., Maresch D., Altmann F., Joensuu J., Conrad U. Influence of elastin-like polypeptide and hydrophobin on recombinant hemagglutinin accumulations in transgenic tobacco plants. PLoS One 2014, 9:e99347.
38. Gutierrez S.P., Saberianfar R., Kohalmi S.E., Menassa R. Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins. BMC Biotechnol 2013, 13:40.
39. Reuter L.J., Bailey M.J., Joensuu J.J., Ritala A. Scale-up of hydrophobin-assisted recombinant protein production in tobacco BY-2 suspension cells. Plant Biotechnol J 2014, 12:402-410.
40. Whitehead M., Ohlschläger P., Almajhdi F.N., Alloza L., Marzábal P., Meyers A.E., Hitzeroth I.I., Rybicki E.P. Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer 2014, 14:367.
41. Vazquez-Villegas P., Espitia-Saloma E., Rito-Palomares M., Aguilar O. Low-abundant protein extraction from complex protein sample using a novel continuous aqueous two-phase systems device. J Sep Sci 2013, 36:391-399.
42. Gecchele E., Schillberg S., Merlin M., Pezzotti M., Avesani L. A downstream process allowing the efficient isolation of a recombinant amphiphilic protein from tobacco leaves. J Chromatogr B Analyt Technol Biomed Life Sci 2014, 960:34-42.
43. Holland T., Blessing D., Hellwig S., Sack M. The in-line measurement of plant cell biomass using radio frequency impedance spectroscopy as a component of process analytical technology. Biotechnol J 2013, 8:1231-1240.
44. Buyel J.F., Fischer R. Characterization of complex systems using the design of experiments approach: transient protein expression in tobacco as a case study. J Vis Exp 2014, 83:e51216. 10.3791/51216.
45. Hassan S., Keshavarz-Moore E., Ma J., Thomas C. Breakage of transgenic tobacco roots for monoclonal antibody release in an ultra-scale down shearing device. Biotechnol Bioeng 2014, 111:196-201.
46. Buyel J.F., Fischer R. Scale-down models to optimize a filter train for the downstream purification of recombinant pharmaceutical proteins produced in tobacco leaves. Biotechnol J 2014, 9:415-425.
47. Tuse D., Tu T., McDonald K.A. Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Biomed Res Int 2014, 2014:352561.
48. Walwyn D.R., Huddy S.M., Rybicki E.P. Techno-economic analysis of horseradish peroxidase production using a transient expression system in Nicotiana benthamiana. Appl Biochem Biotechnol 2014, 10.1007/s12010-014-1320-5.
49. Buyel J.F., Kaever T., Buyel J.J., Fischer R. Predictive models for the accumulation of a fluorescent marker protein in tobacco leaves according to the promoter/5'UTR combination. Biotechnol Bioeng 2013, 110:471-482.
50. Avesani L., Merlin M., Gecchele E., Capaldi S., Brozzetti A., Falorni A., Pezzotti M. Comparative analysis of different biofactories for the production of a major diabetes autoantigen. Transgenic Res 2014, 23:281-291.
51. Merlin M., Gecchele E., Capaldi S., Pezzotti M., Avesani L. Comparative evaluation of recombinant protein production in different biofactories: the green perspective. Biomed Res Int 2014, 2014:136419.
52. Baeshen N.A., Baeshen M.N., Sheikh A., Bora R.S., Ahmed M., Ramadan H.I., Saini K., Redwan E.M. Cell factories for insulin production. Microb Cell Fact 2014, 13:141.
53. Pastores G.M., Petakov M., Giraldo P., Rosenbaum H., Szer J., Deegan P.B., Amato D.J., Mengel E., Tan E.S., Chertkoff R., et al. A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Blood Cells Mol Dis 2014, 53:253-260.
54. Magnusdottir A., Vidarsson H., Bjornsson J.M., Orvar B.L. Barley grains for the production of endotoxin-free growth factors. Trends Biotechnol 2013, 31:572-580.
55. Alfano R., Youngblood B.A., Zhang D., Huang N., MacDonald C.C. Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells. Bioengineered 2014, 5:180-185.
56. Youngblood B.A., Alfano R., Pettit S.C., Zhang D., Dallmann H.G., Huang N., Macdonald C.C. Application of recombinant human leukemia inhibitory factor (LIF) produced in rice (Oryza sativa L.) for maintenance of mouse embryonic stem cells. J Biotechnol 2014, 172:67-72.
57. Wakasa Y., Takagi H., Hirose S., Yang L., Saeki M., Nishimura T., Kaminuma O., Hiroi T., Takaiwa F. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens Cry j 1 and Cry j 2, against Japanese cedar pollinosis. Plant Biotechnol J 2013, 11:66-76.
58. Juarez P., Presa S., Espi J., Pineda B., Anton M.T., Moreno V., Buesa J., Granell A., Orzaez D. Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes. Plant Biotechnol J 2012, 10:341-352.
59. Lindh I., Bråve A., Hallengärd D., Hadad R., Kalbina I., Strid Å., Andersson S. Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses. Vaccine 2014, 32:2288-2293.
60. Karimi F., Mousavi A., Salmanian A., Alizadeh H., Rafati S. Immunogenicity of EIT chimeric protein expressed in transplastomic tobacco plants towards development of an oral vaccine against Escherichia coli O157:H7. Plant Biotechnol Rep 2013, 7:535-546.
61. Kwon K.C., Nityanandam R., New J.S., Daniell H. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. Plant Biotechnol J 2013, 11:77-86.
62. Choi J., Diao H., Feng Z.C., Lau A., Wang R., Jevnikar A.M., Ma S. A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes. Plant Biotechnol J 2014, 12:425-435.
63. Chan H.T., Chia M.Y., Pang V.F., Jeng C.R., Do Y.Y., Huang P.L. Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana. Plant Biotechnol J 2013, 11:315-324.
64. Tokuhara D., Álvarez B., Mejima M., Hiroiwa T., Takahashi Y., Kurokawa S., Kuroda M., Oyama M., Kozuka-Hata H., Nochi T., et al. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest 2013, 123:3829-3838.
65. Pepponi I., Diogo G.R., Stylianou E., van Dolleweerd C.J., Drake P.M., Paul M.J., Sibley L., Ma J.K., Reljic R. Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG. Plant Biotechnol J 2014, 12:840-850.
66. Gorantala J., Grover S., Rahi A., Chaudhary P., Rajwanshi R., Sarin N.B., Bhatnagar R. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine. J Biotechnol 2014, 176:1-10.
67. Mathew L.G., Herbst-Kralovetz M.M., Mason H.S. Norovirus Narita 104 virus-like particles expressed in Nicotiana benthamiana induce serum and mucosal immune responses. Biomed Res Int 2014, 2014:807539.
68. Suzuki K., Kaminuma O., Yang L., Takai T., Mori A., Umezu-Goto M., Ohtomo T., Ohmachi Y., Noda Y., Hirose S., et al. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression. Plant Biotechnol J 2011, 9:982-990.
69. Hongli L., Xukui L., Ting L., Wensheng L., Lusheng S., Jin Z. Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hum Vaccin Immunother 2013, 9:83-89.